|
| |
| | | 66653 | | 05.04.2018 | | MSD Merck Sharp & Dohme AG | | | | | | | | | | | | | 08.03. | | | | 08.03. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Prevymis 240 mg/12 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Letermovirum 240mg / 12ml) | J05AX18 | CI | | 02 | Prevymis 480 mg/24 ml | Konzentrat zur Herstellung einer Infusionslösung | Concentrate for infusion (Letermovirum 480mg / 24ml) | J05AX18 | |
|
|
|
